| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Eton Pharmaceuticals, Inc. | Chief Financial Officer | Common Stock | 205K | $3.28M | $16.02 | Aug 20, 2025 | Direct |
| Eton Pharmaceuticals, Inc. | Chief Financial Officer | Restricted Stock Units | 25.9K | $207K | $7.98 | Jan 3, 2025 | Direct |
| Eton Pharmaceuticals, Inc. | Chief Financial Officer | Employee Stock Option (Right to Buy) | 38.6K | Jan 3, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ETON | Eton Pharmaceuticals, Inc. | Aug 19, 2025 | 2 | -$674K | 4 | Aug 20, 2025 | Chief Financial Officer |
| ETON | Eton Pharmaceuticals, Inc. | Jan 3, 2025 | 2 | $0 | 4 | Jan 6, 2025 | Chief Financial Officer |
| ETON | Eton Pharmaceuticals, Inc. | Feb 13, 2024 | 1 | $0 | 4 | Feb 15, 2024 | Chief Financial Officer |
| ETON | Eton Pharmaceuticals, Inc. | Mar 3, 2023 | 1 | $0 | 4 | Mar 3, 2023 | Chief Financial Officer |
| ETON | Eton Pharmaceuticals, Inc. | Jul 12, 2022 | 1 | $0 | 4 | Jul 18, 2022 | Chief Financial Officer |
| ETON | Eton Pharmaceuticals, Inc. | Apr 11, 2022 | 0 | $0 | 3 | Apr 14, 2022 | Chief Financial Officer |